中國核能科技(00611.HK):舒謙獲委任為董事會主席
格隆匯5月11日丨中國核能科技(00611.HK)發佈公吿,趙翼鑫辭任執行董事、董事會主席以及其於公司董事委員會各職務;劉根鈺辭任董事會副主席,但留任執行董事;符志剛辭任執行董事;唐建華辭任執行董事,但留任公司首席營運官;鍾志成、簡青及李金英辭任執行董事以及彼等於公司董事委員會各職務;及陳嘉齡、田愛平及王季民辭任獨立非執行董事以及彼等於公司董事委員會各職務;自2022年5月10日起生效。
此外,舒謙、李鴻衞、黃艶及劉建榮各自獲委任為執行董事;蘇黎新及許世清各自獲委任為獨立非執行董事;舒謙獲委任為董事會主席;李鴻衞及吳元塵獲委任為董事會副主席;劉根鈺獲委任為公司聯席行政總裁;及符志剛由公司行政總裁調任為公司聯席行政總裁;自2022年5月10日起生效。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.